ÃâÒßѧÊÔÌâ
[l+1zt0w0 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
c3\z 1. Fas(CD95)/FasL
t~xp&LQiY 2. common chain of cytokine receptor
k^|P8v+"D 3 . TCR/CD3 complex
I_Q*uH.Y 5 4. negaive selection of thymocytes
DA[s k7 5. artificial active immune
(6C%w)8' 6. anti-idiotypic
k+^-;=u6< 7. IgSF
C~4$A/&( 8. Integrin
3{mu 77 9. chemokine
1/t}>>,M 10. B7/CD28
R@=Bk(h ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
~E2xIhV 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
Pg3O )D9 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
*/B-%*#I. 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
q?x.P2 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
I'URPj:t
<r*A(}Y 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
[.}-n AN µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
)'{:4MX Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
' LT6%<| 1. B7/CD28
YuWsE4$ 2. Th1 subset
Xa._ 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
l\W[WQPh 4. antibody affinity maturation
Vi~9[&.E\! 5. AP-1
jiPV ]aVN 6. single chain variable fragment£¨ScFv£©
h' OLj#H 7. NK cell receptor
dU]> 8. Zinkernagel-Doherty phenomenon
A*ImruV 9. Ig fold
{0fQ"))"
10. CD40/CD40L
u 89u#gCAC ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
s9 '*Vm 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
$wa )e 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
iw|6w,-)C 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
i)V-q9\ Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
iY~9`Q1E 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
p1 tfN$- 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
]*+ozAG4 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
iYj+NL Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
2U6j?MyH2 £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
kW&{0xkGR Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
i]Or'L0c 1.Co-stimulators (or co-stimulating molecules)
jyPY]r 2.NK-kB
{#CyO
b4 3.Immunoglobulin superfamily
xUE 9%qO 4.antigen-presenting cell (APC)
]@bo; . 5.death domain
=:(8F*Q 6.CCR and CXCR
uY;-x~Z 7.Lectin (or mitogen)
\HFh?3-g 8.Clusters of differentiation, CD)
2s,wC!', 9.B7 family
'j];tO6GfC 10.Cytotoxic T lymphocyte, CTL)
!8]W"@qb 11.IL-15 and IL-15 receptor (IL-15R)
/OaLkENgvf 12.MHC restriction
9 ="i'nYp 13.Affinity-chromatography
Qh-
k[w0 14.Cyctosprin A, CsA
=
wNul" 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
+vfk+6 ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
1tG,V%iCp 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
XiI@Px?FL 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
Dm6WSp1|
b 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
94"R&| Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
o<loc Z ÃâÒßѧרҵ£º
EKf"e*|(L 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
72} MspzUt Ïû»¯ÄÚ¿Æ£º
=x}27f%-Mg 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
(`gqLPx[ ѪҺ²¡Ñ§×¨Òµ£º
ptGM' 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
+2`RvQN Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
a;m-Vu! (רҵ»ù´¡: ÃâÒßѧ)
VN|P(S6 Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
yWu80C8q 1. ADCC(antibody dependent cell-mediated cytotoxicity)
N5[QQtQ 2. »·æß¾úËØ(cyclosporin)
dk
J+*L5 3. KIR(killer cell inhibitory receptor)
!0ySS {/ 4. HLDA(human leucocyte differentiation antigen)
HgE^#qD? 5. Interleukin 18(IL-18)
*nU7v3D
6. ÕûºÏËØ(integrin)
QNzI 7. Fas/FasL
Ix !O&_6s 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
'~%1p_0dq 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
"z
R+} 10. Th1/Th2
&
H;0
N"Fn 11. »ùÒòÒßÃç(DNAÒßÃç)
` :Am#"j]} 12. chemokines and chemokine receptor
Z.<OtsQN 13. ÃâÒßÄÍÊÜ
zS 18Kl 14. ¹²´Ì¼¤·Ö×Ó
XKLkJZN 15. ËÀÍö½á¹¹Óò(death domain)
xl@l< ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
phwk0J]2 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
"zL<:TQ" 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
6;
9SU+/ £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
HlgF%\@a+U £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
f{AbCi £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
)FGm5-K@ £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
NMM0'tY~ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
DG}t! Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
3iJ4VL7 ÎÊ´ðÌâ(ÿÌâ25·Ö)
F#eZfj~ 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
~~,\BhG? 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
l4u_Z:<w 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
'@i/?rNi%N 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£